division of infectious diseases Archives
H. pylori, lipid loss and stomach cancer
Jan. 17, 2022—H. pylori infection — a strong risk factor for stomach cancer — changes the composition of stomach lipids, which could offer new biomarkers for detecting premalignant changes, Vanderbilt researchers discovered.
Bloch, Haas appointed interim leaders of the Division of Infectious Diseases
Jan. 3, 2022—Karen Bloch, MD, MPH, and David Haas, MD, have been appointed interim leaders of the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center.
Who’s who in the respiratory landscape
Nov. 15, 2021—A metatranscriptomics method developed by Vanderbilt researchers simultaneously characterizes viruses, microbiome and host response in nasal swabs, opening opportunities to explore molecular interactions directly in clinical samples.
Wanjalla honored by Doris Duke Foundation
Aug. 12, 2021—Celestine Wanjalla, MD, PhD, assistant professor of Medicine in the Division of Infectious Diseases, is among 17 recipients of the Doris Duke Charitable Foundation 2021 Clinical Scientist Development Award.
Aronoff departing VUMC to become chair of the Department of Medicine at Indiana University School of Medicine
Aug. 11, 2021—David Aronoff, MD, Addison B. Scoville Jr. Professor of Medicine and director of the Division of Infectious Diseases, is departing Vanderbilt University Medical Center to become chair of the Department of Medicine at Indiana University School of Medicine.
Influenza network sizes up COVID
Jul. 22, 2021—Hospital data from a CDC network that monitors influenza revealed that adults hospitalized for COVID-19 in the early months of the pandemic were 20x more likely to die compared to hospitalized influenza patients.
Establishing HIV care in Tennessee
Jul. 13, 2021—Vanderbilt researchers find that heterosexually active Black males are the least likely to establish HIV care within one month of diagnosis and suggest that targeted interventions focus on this population.
New Clinician Spotlight: Titus Daniels
Jun. 16, 2021—Titus Daniels, MD, MPH, MMHC, has returned to Vanderbilt University Medical Center; he was previously on the faculty from 2007 to 2017.
Study finds dramatic gains in life expectancy for people with HIV in Latin America
Apr. 21, 2021—A research team from Vanderbilt University Medical Center and institutions across Latin America today reports what looks to be far the largest study to date of life expectancy for people living with HIV infection in low-income or middle-income countries.
HIV, diabetes and immune cells in fat
Mar. 18, 2021—In HIV-positive individuals with diabetes, immune cells in fat are more proinflammatory and cytotoxic and may represent a therapeutic target for diabetes.
HERO-TOGETHER study seeks health care workers who receive COVID-19 vaccine
Dec. 21, 2020—Health care workers, who have been disproportionately affected by the COVID-19 pandemic, will be the first tier of Vanderbilt University Medical Center employees to receive vaccine to prevent SARS-CoV-2 infection.
Study details early events of inflammatory response
Dec. 10, 2020—Vanderbilt University Medical Center investigators have identified a key molecular player in the early events of the inflammatory response to infection. The findings suggest new therapeutic possibilities for enhancing the inflammatory response to protect against pathogens and for blocking inflammation gone awry in diseases like arthritis and atherosclerosis.
